UniProt ID | STXB5_HUMAN | |
---|---|---|
UniProt AC | Q5T5C0 | |
Protein Name | Syntaxin-binding protein 5 | |
Gene Name | STXBP5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1151 | |
Subcellular Localization |
Cytoplasm. Cell membrane Peripheral membrane protein. Cytoplasmic vesicle membrane Peripheral membrane protein. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle. Cell junction, synapse. Cytoplasmic, and associated with vesicular membranes a |
|
Protein Description | Plays a regulatory role in calcium-dependent exocytosis and neurotransmitter release. Inhibits membrane fusion between transport vesicles and the plasma membrane. May modulate the assembly of trans-SNARE complexes between transport vesicles and the plasma membrane. Inhibits translocation of GLUT4 from intracellular vesicles to the plasma membrane. Competes with STXBP1 for STX1 binding (By similarity).. | |
Protein Sequence | MRKFNIRKVLDGLTAGSSSASQQQQQQHPPGNREPEIQETLQSEHFQLCKTVRHGFPYQPSALAFDPVQKILAVGTQTGALRLFGRPGVECYCQHDSGAAVIQLQFLINEGALVSALADDTLHLWNLRQKRPAILHSLKFCRERVTFCHLPFQSKWLYVGTERGNIHIVNVESFTLSGYVIMWNKAIELSSKSHPGPVVHISDNPMDEGKLLIGFESGTVVLWDLKSKKADYRYTYDEAIHSVAWHHEGKQFICSHSDGTLTIWNVRSPAKPVQTITPHGKQLKDGKKPEPCKPILKVEFKTTRSGEPFIILSGGLSYDTVGRRPCLTVMHGKSTAVLEMDYSIVDFLTLCETPYPNDFQEPYAVVVLLEKDLVLIDLAQNGYPIFENPYPLSIHESPVTCCEYFADCPVDLIPALYSVGARQKRQGYSKKEWPINGGNWGLGAQSYPEIIITGHADGSVKFWDASAITLQVLYKLKTSKVFEKSRNKDDRPNTDIVDEDPYAIQIISWCPESRMLCIAGVSAHVIIYRFSKQEVITEVIPMLEVRLLYEINDVETPEGEQPPPLPTPVGGSNPQPIPPQSHPSTSSSSSDGLRDNVPCLKVKNSPLKQSPGYQTELVIQLVWVGGEPPQQITSLAVNSSYGLVVFGNCNGIAMVDYLQKAVLLNLGTIELYGSNDPYRREPRSPRKSRQPSGAGLCDISEGTVVPEDRCKSPTSGSSSPHNSDDEQKMNNFIEKVKTKSRKFSKMVANDIAKMSRKLSLPTDLKPDLDVKDNSFSRSRSSSVTSIDKESREAISALHFCETFTRKTDSSPSPCLWVGTTLGTVLVIALNLPPGGEQRLLQPVIVSPSGTILRLKGAILRMAFLDTTGCLIPPAYEPWREHNVPEEKDEKEKLKKRRPVSVSPSSSQEISENQYAVICSEKQAKVISLPTQNCAYKQNITETSFVLRGDIVALSNSICLACFCANGHIMTFSLPSLRPLLDVYYLPLTNMRIARTFCFTNNGQALYLVSPTEIQRLTYSQETCENLQEMLGELFTPVETPEAPNRGFFKGLFGGGAQSLDREELFGESSSGKASRSLAQHIPGPGGIEGVKGAASGVVGELARARLALDERGQKLGDLEERTAAMLSSAESFSKHAHEIMLKYKDKKWYQF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
76 | Phosphorylation | QKILAVGTQTGALRL HHHHEECCCCCCHHH | 19.16 | - | |
158 | Phosphorylation | PFQSKWLYVGTERGN CCCCEEEEEEECCCC | 8.84 | - | |
193 | Phosphorylation | AIELSSKSHPGPVVH EEHHHCCCCCCCEEE | 36.54 | 25849741 | |
202 | Phosphorylation | PGPVVHISDNPMDEG CCCEEEECCCCCCCC | 19.23 | 18452278 | |
217 | Phosphorylation | KLLIGFESGTVVLWD CEEEEECCCEEEEEE | 37.19 | 20068231 | |
232 | Phosphorylation | LKSKKADYRYTYDEA CCCCCCCEEEEHHHH | 15.46 | 20068231 | |
234 | Phosphorylation | SKKADYRYTYDEAIH CCCCCEEEEHHHHHH | 11.92 | 20068231 | |
235 | Phosphorylation | KKADYRYTYDEAIHS CCCCEEEEHHHHHHH | 18.59 | 20068231 | |
236 | Phosphorylation | KADYRYTYDEAIHSV CCCEEEEHHHHHHHH | 11.67 | 20068231 | |
242 | Phosphorylation | TYDEAIHSVAWHHEG EHHHHHHHHEEEECC | 13.86 | 20068231 | |
305 | Phosphorylation | VEFKTTRSGEPFIIL EEEEECCCCCCEEEE | 45.47 | 20873877 | |
313 | Phosphorylation | GEPFIILSGGLSYDT CCCEEEEECCCCCCC | 22.02 | 20873877 | |
317 | Phosphorylation | IILSGGLSYDTVGRR EEEECCCCCCCCCCC | 25.00 | 20873877 | |
318 | Phosphorylation | ILSGGLSYDTVGRRP EEECCCCCCCCCCCC | 22.22 | 20873877 | |
320 | Phosphorylation | SGGLSYDTVGRRPCL ECCCCCCCCCCCCEE | 19.34 | 20873877 | |
459 | Phosphorylation | ITGHADGSVKFWDAS EECCCCCCEEECCHH | 23.76 | - | |
502 | Phosphorylation | DIVDEDPYAIQIISW CCCCCCCCHHHEEEE | 28.76 | - | |
542 | Ubiquitination | VITEVIPMLEVRLLY HHHCHHHHHEEEEEE | 3.24 | 24816145 | |
556 | Phosphorylation | YEINDVETPEGEQPP EEECCCCCCCCCCCC | 26.87 | 20058876 | |
657 | Phosphorylation | NGIAMVDYLQKAVLL CCEECHHHHHHHHHH | 10.30 | 20068231 | |
668 | Phosphorylation | AVLLNLGTIELYGSN HHHHCCCCEEECCCC | 17.91 | 20068231 | |
672 | Phosphorylation | NLGTIELYGSNDPYR CCCCEEECCCCCCCC | 13.01 | 20068231 | |
674 | Phosphorylation | GTIELYGSNDPYRRE CCEEECCCCCCCCCC | 25.22 | 20068231 | |
678 | Phosphorylation | LYGSNDPYRREPRSP ECCCCCCCCCCCCCC | 25.76 | 20068231 | |
683 | Ubiquitination | DPYRREPRSPRKSRQ CCCCCCCCCCCCCCC | 55.32 | 24816145 | |
684 | Phosphorylation | PYRREPRSPRKSRQP CCCCCCCCCCCCCCC | 39.51 | 24719451 | |
688 | Phosphorylation | EPRSPRKSRQPSGAG CCCCCCCCCCCCCCC | 37.11 | 23401153 | |
692 | Phosphorylation | PRKSRQPSGAGLCDI CCCCCCCCCCCCCCC | 32.70 | 23401153 | |
700 | Phosphorylation | GAGLCDISEGTVVPE CCCCCCCCCCEECCC | 19.40 | 30108239 | |
703 (in isoform 2) | Phosphorylation | - | 17.80 | 28111955 | |
703 | Phosphorylation | LCDISEGTVVPEDRC CCCCCCCEECCCCCC | 17.80 | 23882029 | |
712 (in isoform 2) | Phosphorylation | - | 36.72 | 26657352 | |
712 | Phosphorylation | VPEDRCKSPTSGSSS CCCCCCCCCCCCCCC | 36.72 | 28060719 | |
714 | Phosphorylation | EDRCKSPTSGSSSPH CCCCCCCCCCCCCCC | 53.46 | 25850435 | |
714 (in isoform 2) | Phosphorylation | - | 53.46 | 28111955 | |
715 | Phosphorylation | DRCKSPTSGSSSPHN CCCCCCCCCCCCCCC | 39.81 | 25850435 | |
715 (in isoform 2) | Phosphorylation | - | 39.81 | 28111955 | |
717 | Phosphorylation | CKSPTSGSSSPHNSD CCCCCCCCCCCCCCC | 27.66 | 25850435 | |
718 | Phosphorylation | KSPTSGSSSPHNSDD CCCCCCCCCCCCCCH | 51.95 | 25850435 | |
719 | Phosphorylation | SPTSGSSSPHNSDDE CCCCCCCCCCCCCHH | 31.69 | 25850435 | |
723 | Phosphorylation | GSSSPHNSDDEQKMN CCCCCCCCCHHHHHH | 43.32 | 18707149 | |
723 (in isoform 2) | Phosphorylation | - | 43.32 | 25849741 | |
726 (in isoform 2) | Phosphorylation | - | 58.03 | 29507054 | |
729 (in isoform 3) | Phosphorylation | - | 5.04 | 22210691 | |
731 (in isoform 3) | Phosphorylation | - | 35.46 | 22210691 | |
732 (in isoform 3) | Phosphorylation | - | 6.92 | 22210691 | |
744 | Phosphorylation | KTKSRKFSKMVANDI HHHHHHHHHHHHHHH | 23.91 | 18669648 | |
749 | Phosphorylation | KFSKMVANDIAKMSR HHHHHHHHHHHHHHH | 29.79 | 33259812 | |
755 | Phosphorylation | ANDIAKMSRKLSLPT HHHHHHHHHHCCCCC | 26.09 | 26074081 | |
759 | Phosphorylation | AKMSRKLSLPTDLKP HHHHHHCCCCCCCCC | 35.02 | 29255136 | |
762 | Phosphorylation | SRKLSLPTDLKPDLD HHHCCCCCCCCCCCC | 60.29 | 30278072 | |
774 | Phosphorylation | DLDVKDNSFSRSRSS CCCCCCCCCCCCCCC | 34.43 | 23927012 | |
776 | Phosphorylation | DVKDNSFSRSRSSSV CCCCCCCCCCCCCCC | 29.21 | 24260401 | |
778 | Phosphorylation | KDNSFSRSRSSSVTS CCCCCCCCCCCCCEE | 35.00 | 25159151 | |
780 | Phosphorylation | NSFSRSRSSSVTSID CCCCCCCCCCCEECC | 28.36 | 23927012 | |
781 | Phosphorylation | SFSRSRSSSVTSIDK CCCCCCCCCCEECCH | 27.93 | 25463755 | |
782 | Phosphorylation | FSRSRSSSVTSIDKE CCCCCCCCCEECCHH | 30.57 | 29255136 | |
784 | Phosphorylation | RSRSSSVTSIDKESR CCCCCCCEECCHHHH | 23.16 | 23927012 | |
785 | Phosphorylation | SRSSSVTSIDKESRE CCCCCCEECCHHHHH | 27.00 | 23927012 | |
790 | Phosphorylation | VTSIDKESREAISAL CEECCHHHHHHHHHH | 40.96 | 23403867 | |
851 | Ubiquitination | IVSPSGTILRLKGAI EECCCCHHHHHHHHH | 2.10 | 24816145 | |
855 | Malonylation | SGTILRLKGAILRMA CCHHHHHHHHHHHHH | 39.60 | 26320211 | |
871 | Ubiquitination | LDTTGCLIPPAYEPW ECCCCCCCCCCCCCH | 4.46 | 24816145 | |
887 | Ubiquitination | EHNVPEEKDEKEKLK HCCCCCCHHHHHHHH | 70.31 | 24816145 | |
900 | Phosphorylation | LKKRRPVSVSPSSSQ HHHCCCCCCCCCCCC | 21.40 | 21712546 | |
902 | Phosphorylation | KRRPVSVSPSSSQEI HCCCCCCCCCCCCCC | 16.14 | 23401153 | |
904 | Phosphorylation | RPVSVSPSSSQEISE CCCCCCCCCCCCCCC | 34.81 | 28450419 | |
905 | Phosphorylation | PVSVSPSSSQEISEN CCCCCCCCCCCCCCC | 39.15 | 30576142 | |
906 | Phosphorylation | VSVSPSSSQEISENQ CCCCCCCCCCCCCCC | 35.85 | 21712546 | |
910 | Phosphorylation | PSSSQEISENQYAVI CCCCCCCCCCCEEEE | 29.73 | 28450419 | |
914 | Phosphorylation | QEISENQYAVICSEK CCCCCCCEEEECCHH | 17.89 | 28450419 | |
919 | Phosphorylation | NQYAVICSEKQAKVI CCEEEECCHHHCEEE | 36.38 | 28450419 | |
924 | Malonylation | ICSEKQAKVISLPTQ ECCHHHCEEEECCCC | 37.29 | 26320211 | |
975 | Phosphorylation | IMTFSLPSLRPLLDV EEEEECCCCHHHEEE | 42.16 | 24719451 | |
1039 | Phosphorylation | ELFTPVETPEAPNRG HHCCCCCCCCCCCCC | 27.02 | 26657352 | |
1058 | Phosphorylation | LFGGGAQSLDREELF CCCCCCCCCCHHHHH | 31.53 | 30624053 | |
1076 | Phosphorylation | SSGKASRSLAQHIPG CCCHHHHHHHHCCCC | 26.09 | 27535140 | |
1127 | Phosphorylation | ERTAAMLSSAESFSK HHHHHHHHCHHHHHH | 17.89 | 25072903 | |
1128 | Phosphorylation | RTAAMLSSAESFSKH HHHHHHHCHHHHHHH | 31.90 | 23401153 | |
1131 | Phosphorylation | AMLSSAESFSKHAHE HHHHCHHHHHHHHHH | 34.24 | 23401153 | |
1133 | Phosphorylation | LSSAESFSKHAHEIM HHCHHHHHHHHHHHH | 32.58 | 28857561 | |
1142 | Methylation | HAHEIMLKYKDKKWY HHHHHHHHCCCCCCC | 32.64 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
723 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STXB5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STXB5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of STXB5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-785, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-759; SER-782 ANDSER-785, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-784 AND SER-785, ANDMASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-759, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-762, AND MASSSPECTROMETRY. |